BioCryst Pharmaceuticals shares owned by Virtus ETF Advisers
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Virtus ETF Advisers
from 13F filings
Historical chart of Virtus ETF Advisers investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Virtus ETF Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Virtus ETF Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $402k | 53k | 7.60 |
| 2024-06-30 | $327k | 53k | 6.18 |
| 2024-03-31 | $301k | 59k | 5.08 |
| 2023-12-31 | $304k | 51k | 5.99 |
| 2023-09-30 | $271k | 38k | 7.08 |
| 2023-06-30 | $305k | 43k | 7.04 |
| 2023-03-31 | $230k | 28k | 8.34 |
| 2022-12-31 | $311k | 27k | 11.48 |
| 2022-09-30 | $314k | 25k | 12.60 |
| 2022-06-30 | $260k | 25k | 10.59 |
| 2022-03-31 | $529k | 33k | 16.26 |
| 2021-12-31 | $451k | 33k | 13.86 |
| 2021-09-30 | $404k | 28k | 14.38 |
| 2021-06-30 | $485k | 31k | 15.81 |
| 2021-03-31 | $359k | 35k | 10.16 |
| 2020-12-31 | $259k | 35k | 7.46 |
| 2020-09-30 | $247k | 72k | 3.44 |
| 2020-06-30 | $389k | 82k | 4.76 |
| 2020-03-31 | $242k | 121k | 2.00 |
| 2019-12-31 | $479k | 139k | 3.45 |
| 2019-09-30 | $214k | 75k | 2.87 |
| 2019-06-30 | $298k | 79k | 3.79 |
| 2019-03-31 | $255k | 31k | 8.15 |
| 2018-12-31 | $285k | 35k | 8.07 |
| 2018-09-30 | $637k | 84k | 7.63 |
| 2018-06-30 | $820k | 143k | 5.73 |
| 2018-03-31 | $735k | 154k | 4.77 |
| 2017-12-31 | $349k | 71k | 4.91 |
| 2017-09-30 | $298k | 57k | 5.24 |
| 2017-06-30 | $287k | 52k | 5.55 |
| 2017-03-31 | $427k | 51k | 8.39 |
| 2016-12-31 | $291k | 46k | 6.32 |
| 2016-09-30 | $374k | 85k | 4.40 |
| 2016-06-30 | $241k | 85k | 2.84 |
| 2016-03-31 | $74k | 26k | 2.82 |